Mckesson (MCK) Liabilities and Shareholders Equity (2009 - 2026)
Mckesson (MCK) reported Liabilities and Shareholders Equity of $82.3 billion for Q1 2026, up 9.56% year-over-year from $75.1 billion in Q1 2025, and down 2.22% quarter-over-quarter from $84.2 billion in Q4 2025.
Mckesson (MCK) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $82.3 billion in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $82.3 billion, up 9.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $332.0 billion (up 14.35% YoY), and the FY2026 annual result was $82.3 billion, up 9.56% from the prior year.
- Liabilities and Shareholders Equity eased to $82.3 billion in Q1 2026 per MCK's latest filing, from $84.2 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $84.2 billion in Q4 2025 and troughed at $62.3 billion in Q2 2022.
- A 5-year average of $70.6 billion and a median of $67.4 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity declined 2.64% in 2022, then rose 18.44% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $62.7 billion in 2022, then gained by 6.1% to $66.5 billion in 2023, then climbed by 6.87% to $71.1 billion in 2024, then advanced by 18.44% to $84.2 billion in 2025, then fell by 2.22% to $82.3 billion in 2026.
- Business Quant data shows MCK's Liabilities and Shareholders Equity at $82.3 billion in Q1 2026, $84.2 billion in Q4 2025, and $84.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 212.04 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 82.32 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 81.65 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 56.69 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 11.30 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.42 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 72.06 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 310.22 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 62.37 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.32 Bn |
| Dec 31, 2025 | 84.19 Bn |
| Sep 30, 2025 | 84.16 Bn |
| Jun 30, 2025 | 81.31 Bn |
| Mar 31, 2025 | 75.14 Bn |
| Dec 31, 2024 | 71.08 Bn |
| Sep 30, 2024 | 72.43 Bn |
| Jun 30, 2024 | 71.67 Bn |
| Mar 31, 2024 | 67.44 Bn |
| Dec 31, 2023 | 66.51 Bn |
| Sep 30, 2023 | 66.09 Bn |
| Jun 30, 2023 | 64.10 Bn |
| Mar 31, 2023 | 62.32 Bn |
| Dec 31, 2022 | 62.69 Bn |
| Sep 30, 2022 | 63.08 Bn |
| Jun 30, 2022 | 62.30 Bn |
| Mar 31, 2022 | 63.30 Bn |
| Dec 31, 2021 | 63.71 Bn |
| Sep 30, 2021 | 63.60 Bn |
| Jun 30, 2021 | 62.89 Bn |